• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

    32.30 +0.16 (+0.50%)
    Streaming Delayed Price Updated: 4:00 PM EST, Jan 6, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,677,201
    Open 31.88
    Bid (Size) 32.36 (300)
    Ask (Size) 32.48 (1,900)
    Prev. Close 32.14
    Today's Range 31.56 - 33.28
    52wk Range 18.92 - 43.55
    Shares Outstanding 99,581,693
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    The Great 2026 Pivot: Tech and Healthcare Surge as Broader Market Rally Hits a Wall
    As the first week of 2026 comes to a close, the financial markets are undergoing a significant structural shift. The broad-based "rising tide" that lifted almost all sectors throughout 2025 has begun... 
    Via MarketMinute
    Topics Artificial Intelligence Economy Stocks
    News headline image
    Viking Therapeutics Stock Suffers Worst Day In Over 4 Months As Top Execs Dump Shares — Novo’s $149 Wegovy Move Looms ↗
    Novo’s pricing applies to lower-dose oral Wegovy, with higher doses set at higher monthly prices. 
    Via Stocktwits

    Performance

    YTD
    -8.8%
    -8.8%
    1 Month
    -15.0%
    -15.0%
    3 Month
    +0.1%
    +0.1%
    6 Month
    +17.4%
    +17.4%
    1 Year
    -24.1%
    -24.1%

    More News

    Read More
    News headline image
    The GLP-1 Pricing Revolution: How Novo Nordisk and Eli Lilly Redefined the Weight-Loss Market for 2026
    Via MarketMinute
    Topics Economy Intellectual Property
    News headline image
    2 Beaten-Down Stocks That Could Bounce Back in 2026 ↗
    Via The Motley Fool
    News headline image
    The Motley Fool Rule Breakers Besties of 2025 ↗
    Via The Motley Fool
    News headline image
    The Oral Revolution: Novo Nordisk’s High-Stakes Bet on the Wegovy Pill
    Via PredictStreet
    Topics Economy Intellectual Property World Trade
    News headline image
    The Trillion-Dollar Pharma: A Deep Dive into Eli Lilly’s (LLY) Dominance in the Weight-Loss Era
    Via PredictStreet
    Topics Economy Government Intellectual Property
    News headline image
    The Weight of Innovation: Eli Lilly’s Dominance in the GLP-1 Era
    Via PredictStreet
    Topics Economy
    News headline image
    Novo Nordisk Stock Soars as "Wegovy Pill" Gains FDA Approval, Reshaping Obesity Market
    Via MarketMinute
    News headline image
    The Great Rotation: Small-Caps Break All-Time Highs as Investors Pivot from Mega-Tech
    Via MarketMinute
    Topics Artificial Intelligence Economy Initial Public Offering
    News headline image
    The Great Rotation: Why the Russell 2000 is Finally Outpacing the Giants in Late 2025
    Via MarketMinute
    Topics Artificial Intelligence Bonds Economy
    News headline image
    Eli Lilly’s Oral Obesity Drug Passes Maintenance Test After Wegovy, Zepbound — Wall Street Flags Win For Viking Therapeutics ↗
    Via Stocktwits
    News headline image
    2 Growth Stocks to Invest $1,000 in Right Now ↗
    Via The Motley Fool
    News headline image
    1 Bold Prediction for Viking Therapeutics in 2026 ↗
    Via The Motley Fool
    News headline image
    2 Monster Stocks in the Making to Buy and Hold ↗
    Via The Motley Fool
    News headline image
    My Top 10 Stocks to Buy for 2026 ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    3 Underrated Growth Stocks That Look Like Great Buys Heading Into 2026 ↗
    Via The Motley Fool
    Topics Artificial Intelligence ETFs
    News headline image
    What's Up With The Jump In Viking Therapeutics Stock? ↗
    Via Benzinga
    News headline image
    Prediction: This Undervalued Stock Could Compete With Novo Nordisk by 2029 ↗
    Via The Motley Fool
    News headline image
    Retail Traders Crown Novo Nordisk As Long-Term Weight Loss King — Even As Eli Lilly Hits $1T And Viking Fans Tout ‘M&A Prize’ ↗
    Via Stocktwits
    News headline image
    2 Healthcare Stocks for Beginner Investors With a 20-Year Time Horizon ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    3 Mid-Cap Growth Stocks That Have Mammoth Long-Term Potential ↗
    Via The Motley Fool
    News headline image
    Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗
    Via The Motley Fool
    News headline image
    5AM Venture Just Dumped Its Viking Stake—Smart Call or Missed Opportunity? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    2 No-Brainer Healthcare Stocks to Buy Now ↗
    Via The Motley Fool

    Frequently Asked Questions

    Is Viking Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Viking Therapeutics, Inc. - Common Stock trade on?
    Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?
    The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market
    What is the current price of Viking Therapeutics, Inc. - Common Stock?
    The current price of Viking Therapeutics, Inc. - Common Stock is 32.30
    When was Viking Therapeutics, Inc. - Common Stock last traded?
    The last trade of Viking Therapeutics, Inc. - Common Stock was at 01/06/26 04:00 PM ET
    What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?
    The market capitalization of Viking Therapeutics, Inc. - Common Stock is 3.22B
    How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?
    Viking Therapeutics, Inc. - Common Stock has 3B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.